2 results
Approved WMORecruiting
The proposed pilot study will examine whether radiation-based CTA could be replaced with MRI in three phases of AAA management.
Approved WMOCompleted
Part 1: The primary objective of this study is to evaluate the efficacy of natalizumab extended interval dosing (EID) in subjects who have previously been treated with natalizumab standard interval dosing (SID) for at least 12 months, in relation to…